Iniesta-Navalón, C <br/><br/>
Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approach.  [electronic resource] 

 -  HIV medicine  May 2015 
 - 273-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1468-1293 
<br/><br/><label>Standard No.: </label>10.1111/hiv.12205  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Adverse Drug Reaction Reporting Systems<br/>Aged<br/>Aged, 80 and over<br/>Anti-HIV Agents--administration & dosage<br/>Comorbidity<br/>Cross-Sectional Studies<br/>Drug Administration Schedule<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Female<br/>HIV Fusion Inhibitors--administration & dosage<br/>HIV Infections--drug therapy<br/>HIV Integrase Inhibitors--administration & dosage<br/>HIV Protease Inhibitors--administration & dosage<br/>Hepatitis B--drug therapy<br/>Hepatitis C--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Phosphodiesterase 5 Inhibitors--administration & dosage<br/>Practice Patterns, Physicians'<br/>Prevalence<br/>Reverse Transcriptase Inhibitors--administration & dosage<br/>Risk Factors<br/>Spain--epidemiology